Toshiba spotlights contrast-free MRA
Providers can eliminate the use of gadolinium-based contrast by using new pulse sequences from Toshiba America Medical Systems. The angiography techniques rely on differences in the MR signal that distinguish blood and surrounding soft tissue.
Providers can eliminate the use of gadolinium-based contrast by using new pulse sequences from Toshiba America Medical Systems. The angiography techniques rely on differences in the MR signal that distinguish blood and surrounding soft tissue. The company showcased Fresh Blood Imaging, Contrast-free Improved Angiography, and Time-spatial Labeling Inversion Pulse, positioning these contrast-free imaging techniques as alternatives to gadolinium-based agents. The use of such agents has been associated with the occurrence of nephrogenic systemic fibrosis.
Can Deep Learning Ultra-Fast bpMRI Have an Impact in Prostate Cancer Imaging?
March 3rd 2025A deep learning-enhanced ultra-fast bpMRI protocol offered similar sensitivity for csPCa as mpMRI with an 80 percent reduction in scan time, according to research findings presented at the European Congress of Radiology (ECR) conference.
Emerging AI Software for Prostate MRI Offers 95 Percent Sensitivity for csPCa
February 28th 2025In a multicenter study involving over 1,000 patients, a deep learning software offered comparable sensitivity and specificity for Gleason grade group > 2 tumors in comparison to radiologist interpretation.
